Adiponectin and insulin sensitivity in primary aldosteronism.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Hypertension

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJHYPER.2007.03.012PMID 17679033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aldosterone as a Cardiovascular Risk Factor

  2007cited by this paper
• Adiponectin and hypertension: a putative link between adipocyte function and atherosclerotic risk?

  2007cited by this paper
• Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study

  2007cited by this paper
• Metabolic safety of antihypertensive drugs: Myth versus reality

  2006cited by this paper
• Comparison of confirmatory tests for the diagnosis of primary aldosteronism.

  2006cited by this paper
• New treatment strategies for patients with hypertension and insulin resistance.

  2006cited by this paper
• Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

  2006cited by this paper
• Cardiovascular Diabetology BioMed Central Original investigation Increased proinflammatory endothelial response to S100A8/A9

  2006cited by this paper
• Insulin sensitivity in patients with primary aldosteronism: a follow-up study.

  2006cited by this paper
• Role of the renin-angiotensin- aldosterone system in the metabolic syndrome.

  2006cited by this paper
• Low plasma adiponectin concentration is an indicator of the metabolic syndrome.

  2006cited by this paper
• Adiponectin Replenishment Ameliorates Obesity-Related Hypertension

  2006cited by this paper
• The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.

  2005cited by this paper
• Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

  2005cited by this paper
• Aldosterone as a cardiovascular risk factor.

  2005cited by this paper
• Diagnosis of primary aldosteronism: from screening to subtype differentiation.

  2005cited by this paper
• Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

  2005cited by this paper
• Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients.

  2005cited by this paper
• Review article: adipocytokines and insulin resistance

  2005cited by this paper
• Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders.

  2004cited by this paper
• Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome.

  2004cited by this paper
• The effect of aldosterone on glucose metabolism

  2003cited by this paper
• Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease.

  2003cited by this paper
• Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism

  2002cited by this paper
• Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension.

  2001cited by this paper
• Triggering and amplifying pathways of regulation of insulin secretion by glucose.

  2000cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• Insulin resistance in secondary hypertension.

  1992cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2563–2568 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2004-0518 Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function

  year unknowncited by this paper

• Advancing kidney protection in type 1 diabetes: insights from emerging therapies in type 2 diabetes and chronic kidney disease

  2025cites this paper
• Glucocorticoids: The culprit behind metabolic disorders in primary Aldosteronism? A narrative review

  2025cites this paper
• Occurrence of Metabolic Disorders in Bilateral Primary Aldosteronism Compared to Unilateral Primary Aldosteronism

  2025cites this paper
• The association between aldosterone and lipid profiles in patients with primary aldosteronism

  2025cites this paper
• Association of serum cortisol with insulin secretion and plasma aldosterone with insulin resistance in untreated type 2 diabetes: a cross-sectional study

  2025cites this paper
• The prevalence of metabolic syndrome in primary aldosteronism and essential hypertension: A systematic review and meta‐analysis

  2024cites this paper
• Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism

  2022influential citation
• The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review

  2022cites this paper
• Secondary diabetes mellitus due to primary aldosteronism

  2022cites this paper
• Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight

  2022cites this paper
• Differences in Glycemic Abnormalities Between Primary Aldosteronism and Essential Hypertension: A Systematic Review and Meta-Analysis

  2022cites this paper
• Association of renin and aldosterone with glucose metabolism in a Western European population: the KORA F4/FF4 study

  2022cites this paper
• Immunohistochemical Analysis of CYP11B2, CYP11B1 and β-catenin Helps Subtyping and Relates With Clinical Characteristics of Unilateral Primary Aldosteronism

  2021cites this paper
• The Association Between Dietary Intake of Sodium, Potassium, and Na:K Ratio with the Risk of NAFLD: A Case–Control Study Among Iranian Adults

  2021cites this paper
• Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism

  2021cites this paper
• Type 2 diabetes mellitus caused by Gitelman syndrome-related hypokalemia

  2020cites this paper
• The role of selected adipokines in tumorigenesis and metabolic disorders in patients with adrenal tumors

  2020cites this paper
• Higher prevalence of metabolic disorders in patients with bilateral primary aldosteronism than unilateral primary aldosteronism

  2020cites this paper
• Assessment of Glycometabolism Impairment and Glucose Variability Using Flash Glucose Monitoring System in Patients With Adrenal Diseases

  2020cites this paper
• Links between aldosterone excess and metabolic complications: A comprehensive review.

  2020cites this paper
• Adipocyte Mineralocorticoid Receptor.

  2019cites this paper
• Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea—what do we know so far?

  2019cites this paper
• Iron-related parameters in adipose tissue and blood in diabetes mellitus

  2018cites this paper
• Adiponectin and Aldosterone in Left Ventricular Hypertrophy: An Intriguing Interplay

  2018cites this paper
• Association of Papillary Thyroid Carcinoma with Primary Aldosteronism

  2018cites this paper
• Adipokine and cytokine levels in non-functioning adrenal incidentalomas (NFAI).

  2018cites this paper
• Effects of Aldosterone on Chemerin Expression And Secretion in 3T3-L1 Adipocytes.

  2017cites this paper
• Impact of Adrenal Steroids on Regulation of Adipose Tissue.

  2017cites this paper
• 3.09 – Aldosterone Action on Brain and Behavior

  2017cites this paper
• The McKittrick–Wheelock syndrome: a rare cause of curable diabetes

  2016cites this paper
• Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney.

  2016cites this paper
• АЛЬДОСТЕРОН И ОЖИРЕНИЕ: ГДЕ ИСКАТЬ КЛЮЧ К ТЕРАПИИ?

  2016cites this paper
• АЛЬДОСТЕРОН И ОЖИРЕНИЕ: ГДЕ ИСКАТЬ КЛЮЧ К ТЕРАПИИ?

  2016cites this paper
• Primary aldosteronism as an endocrinological challenge – old doubts and new diagnostic possibilities

  2016cites this paper
• Aldosterone and type 2 diabetes mellitus

  2016cites this paper
• The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy

  2015cites this paper
• Higher blood aldosterone level in metabolic syndrome is independently related to adiposity and fasting plasma glucose

  2015cites this paper
• Endocrine causes of nonalcoholic fatty liver disease.

  2015cites this paper
• RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.

  2015cites this paper
• Hypertension and Dyslipidemia in Patients with Pre-Diabetes: Dietary and Other Therapies

  2015cites this paper
• Changes in potassium concentration and gene expression in mice fed a high-fat diet

  2015cites this paper
• Pharmacological treatment of aldosterone excess.

  2015cites this paper
• Primary Aldosteronism

  2014cites this paper
• Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.

  2014cites this paper
• Aldosterone and Cardiovascular Diseases

  2014cites this paper
• Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis

  2014cites this paper
• Effects of aldosterone on insulin sensitivity and secretion.

  2014cites this paper
• Paradoxical resistance to high-fat diet-induced obesity and altered macrophage polarization in mineralocorticoid receptor-overexpressing mice.

  2014cites this paper
• Diabetes in Hyperaldosteronism

  2014cites this paper
• Effect of renin inhibition on adipokines in diabetic rats.

  2014cites this paper
• Serum potassium level is associated with metabolic syndrome: a population-based study.

  2014cites this paper
• Adipokines: Novel Players in Resistant Hypertension

  2014cites this paper
• Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders

  2014cites this paper
• Aldosterone Excess and Resistant Hypertension: Investigation and Treatment

  2014cites this paper
• Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.

  2013cites this paper
• The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans

  2013cites this paper
• Aldosterone directly affects apelin expression and secretion in adipocytes.

  2013cites this paper
• How should we treat hypertension and dyslipidemia in patients with prediabetes?

  2013cites this paper
• Primary Aldosteronism: Progress in Diagnosis, Therapy, and Genetics

  2013cites this paper
• Vers l'identification de nouveaux effets métaboliques du récepteur des minéralocorticoïdes

  2012cites this paper
• Treatment with heme arginate alleviates adipose tissue inflammation and improves insulin sensitivity and glucose metabolism in a rat model of Human primary aldosteronism.

  2012cites this paper
• Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients.

  2012cites this paper
• Role of mineralocorticoid receptor in insulin resistance

  2012cites this paper
• Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists.

  2012cites this paper
• Primary Aldosteronism and Metabolic Syndrome

  2011cites this paper
• Cardiac Hypertrophy and Fibrosis in the Metabolic Syndrome: A Role for Aldosterone and the Mineralocorticoid Receptor

  2011cites this paper
• Approach to the hospitalized patient with severe insulin resistance.

  2011cites this paper
• Complicanze cardiometaboliche e renali nell’iperaldosteronismo primario

  2011cites this paper
• Combining body mass index and serum potassium to urine potassium clearance ratio is an alternative method to predict primary aldosteronism.

  2011cites this paper
• Primary Aldosteronism: Who Should be Screened?

  2011cites this paper
• Aldosterone, from (patho)physiology to treatment in cardiovascular and renal damage.

  2011cites this paper
• Interaction between Adiponectin and Aldosterone

  2011cites this paper
• Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome

  2011influential citation
• The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension.

  2010cites this paper
• Adipokines and cardiometabolic profile in primary hyperaldosteronism.

  2010influential citation
• Metabolic syndrome and primary aldosteronism: time for reappraisal?

  2010cites this paper
• Confirmatory Tests in the Diagnosis of Primary Aldosteronism

  2010cites this paper
• The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism

  2010cites this paper
• Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.

  2010cites this paper
• The Relationship Between Osteopontin and Adiponectin in Patients with Essential Hypertension

  2010cites this paper
• Adiponectin - A possible factor in the pathogenesis of carbohydrate metabolism disturbances in patients with pheochromocytoma.

  2010cites this paper
• Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study.

  2010cites this paper
• Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.

  2010cites this paper
• Primary Aldosteronism Complicated by Severe Hypokalemic Myopathy

  2010cites this paper
• Mineralocorticoid Receptor Antagonists and the Metabolic Syndrome

  2010cites this paper
• Primary aldosteronism: an update

  2010cites this paper
• Update in primary aldosteronism.

  2009cites this paper
• Role of aldosterone and angiotensin II in insulin resistance: an update

  2009cites this paper
• Update in primary aldosteronism.

  2009cites this paper
• Mineralocorticoid receptors in the metabolic syndrome.

  2009cites this paper
• Comparing the Prevalence of Primary Aldosteronism in Hypertensive Diabetic and Non-diabetic Patients

  2009cites this paper
• Aldosterone and cardiovascular disease.

  2009cites this paper
• Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension.

  2009cites this paper
• The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways.

  2009cites this paper
• Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension

  2009cites this paper
• Insulin resistance and blood pressure

  2008cites this paper
• The renin–angiotensin–aldosterone system: a pivotal role in insulin sensitivity and glycemic control

  2008cites this paper
• A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function.

  2008cites this paper
• Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients

  2008cites this paper
• Aldosterone and Hypertension in the Cardiometabolic Syndrome

  2008cites this paper